Last Updated on February 22, 2026 1:28 am by BIZNAMA NEWS
S. N. Verma / New Delhi
Union Minister of State (Independent Charge) for Science and Technology and Minister of Earth Sciences, Prime Ministers Office, Personnel, Public Grievances & Pensions and Atomic Energy and Space Dr. Jitendra Singh today said that the tools developed from artificial intelligence (AI) are now working towards eliminating individual predictions or gaps in test results in medical investigations. This will ensure more accurate and clear treatment to patients.
Delivering the inaugural address at the Medlumina 2026 International Multi Speciality Medical Conference, Dr. Jitendra Singh gave the example that when a pathologist is examining the biopsy slide of a cancer patient with the naked eye, he may inadvertently miss testing a small but necessary cluster of affected cells, while an AI-enabled system can guide him to the right place, thereby minimizing human errors. Similarly, in clinical testing, AI tools that analyze entire patient data can mark outcomes that can be ignored. This increases test accuracy and leads to better treatment outcomes.
Emphasizing the importance of integrated medicine dialogue, Dr. Jitendra Singh said that with increasing super-specialization, opportunities for cross-disciplinary dialogue are often reduced. A multi-specialty academic platform organized by a testing institute presents a forward-thinking approach, especially at a time when drugs are becoming more interdisciplinary, including Medtech, Engineering, and Advanced Data Science.
Referring to the development of medical science in the last few decades, Dr. Jitendra Singh mentioned the change in the era of imaging and molecular tools, ultrasound, CT scan, MRI and now genomics from the era of classical clinical learning. He said that today’s saying has changed where earlier medical mastery depended only on reading too much, today AI-enabled systems meet and improve clinical judgment. He also pointed out that AI-powered language tools are removing communication barriers in healthcare, making it possible to reach more people through mobile clinics and digital platforms.
The Union Minister spoke in detail about the changing scope of diseases in India. He spoke of region-specific diseases in the past, such as diabetes in southern India or thyroid problems in the Himalayan regions, now common across the country, due to lifestyle changes. At the same time, there has been a change in the pattern of different diseases that occur in villages and cities earlier. Age-related diseases have emerged, while lifestyle-related diseases are emerging at a younger age. In this case, early and correct diagnosis has become very necessary to differentiate between similar clinical and prevent the wrong treatment approaches.
Dr. Jitendra Singh emphasized that India is entering a new era of genomics and gene therapy. A large-scale genome sequencing initiative is underway under the Department of Biotechnology, with the initial goal of sequencing one million people. He noted the successful medical research in gene therapy for hemophilia, which was conducted in collaboration with large medical institutions, and called it a major scientific achievement. He also mentioned the development of India’s first indigenous antibiotic, naphithromycin, which is a testament to the country’s growing life sciences capabilities.
He further said that in the coming decades, individual-specific medical recommendations based on genetic profiling, environmental factors and lifestyle determinants will become common. Together with AI-Driven diagnostic analytics, Genomic Insights, clinicians will help design specific treatments for each patient, rather than adopting the same approach for every patient.
Dr. Jitendra Singh also spoke about the policy reforms aimed at advancing India’s research ecology. The government has opened up areas such as space, nuclear medicine and advanced health research to greater private participation, creating a good framework for innovation. He invited large diagnostic institutions to work closely with government research initiatives, and said the combination of government and private forces would lead to rapid success in areas such as nuclear medicine therapy and advanced oncology treatment.
Linking healthcare to a broader national perspective, the Union Minister said that more than 70 percent of India’s population is below the age of 40, so health protection and the use of youth’s energy is essential to create a “Developed India”. A robust diagnostics ecosystem backed by AI, genomics and trustworthy quality full standards will play a key role in ensuring that therapeutic and accurate drugs are accessible to all.
The conference concluded with a shared commitment to upgrading medical testing, strengthening mutual cooperation in various medical fields, and using AI-driven tools to create a future-ready healthcare system in India.
